Research Article

The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis

Volume: 12 Number: 3 December 31, 2022
EN

The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis

Abstract

Objective: Oral submucous fibrosis (OSF) is a disease characterized by abnormal collagen deposition that causes inflammation and malignancy in oral mucosal tissue. Fibroblasts and myofibroblasts, are the cells that show significant activation in the development of OSF. Bleomycin (BL) is a chemotherapeutic agent commonly used in cancer treatment that also causes inflammatory changes in the oral mucosa, initiating fibrosis in the oral submucosal tissue. Sesamol (SE) has antioxidative and anti-inflammatory properties which are abundant in sesame seeds and sesame oil, and SE has a beneficial effect on the mucosal layer. This experimental study aimed to investigate SE’s effects on BL-induced OSF.

Materials and Methods: The study obtained 18 healthy adult male albino rats aged 3-4 months and weighing 200-250g from Bolu Abant Izzet Baysal University’s Experimental Animal Application and Research Center. The rats were divided randomly into control, BL, and BL + SE groups (n = 6 in each group). A model of OSF was established in the rats by administering 0.5 mg/mL of BL and 50 mg\kg of SE to the BL+SE group each day. The hematoxylin and eosin stain and Masson’s trichrome stain were used to assess histopathological changes in the oral mucosa.

Results: The results revealed SE to have beneficial effects on BL-induced OSF through its antioxidant and anti-inflammatory properties. Histopathological evaluations and biochemical analysis of oral submucosal tissue samples also revealed SE to provide statistically significant protection against fibrosis in the oral mucosa (p < 0.01).

Conclusion: This study has demonstrated oral submucous fibrosis that develops due to BL as well as SE to have an antioxidant effect on OSF regarding BL-induced reactive oxygen species (ROS) activation and collagen synthesis

Keywords

Thanks

We thanks to Prof.Dr. Mehmet Aydın for his contribution to the statistical analysis of this study.

References

  1. 1. World Health Organization; International Agency for Research on Cancer. IARC monograph on the evaluation of carcinogenic risks to humans, betel-quid and areca-nut chewing and some arecanut-derived nitrosamines. Vol. 85. Lyon, France: IARC; 2004. google scholar
  2. 2. Arakeri G, Brennan PA. Oral submucous fibrosis: An overview of the aetiology, pathogenesis, classification, and principles of management. Br J Oral Maxillofac Surg 2013; 51: 587-93. [CrossRef] google scholar
  3. 3. Angadi PV, Kale AD, Hallikerimath S. Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity. J Oral Pathol Med 2011; 40: 208-13. [CrossRef] google scholar
  4. 4. Kerr AR, Warnakulasuriya S, Mighell AJ, T Dietrich, M Nasser, J Rimal, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis 2011; 17: 42-57. [CrossRef] google scholar
  5. 5. Jiang XW, Zhang Y, Yang SK, Zhang H, Lu K, Sun GL. Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: 339-44. [CrossRef] google scholar
  6. 6. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: Searching for model answers. Am J Respir Cell Mol Biol 2005; 33: 9-13. [CrossRef] google scholar
  7. 7. Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, et al. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999; 112: 456-62. [CrossRef] google scholar
  8. 8- Zhang SS, Gong ZJ, Xiong W, Wang X, Min Q, Luo CD, et al. A rat model of oral submucous fibrosis induced by bleomycin. Oral Surg Oral Med Oral Pathol Oral Radiol 2016; 122(2): 216-23. [CrossRef] google scholar

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

December 31, 2022

Submission Date

October 27, 2022

Acceptance Date

December 17, 2022

Published in Issue

Year 2022 Volume: 12 Number: 3

APA
Erimşah, S., Çetinkaya, A., Üyetürk, Ü., Üyetürk, U., & Yazır, Y. (2022). The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis. Experimed, 12(3), 238-242. https://doi.org/10.26650/experimed.1195246
AMA
1.Erimşah S, Çetinkaya A, Üyetürk Ü, Üyetürk U, Yazır Y. The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis. Experimed. 2022;12(3):238-242. doi:10.26650/experimed.1195246
Chicago
Erimşah, Sevilay, Ayhan Çetinkaya, Ümmügül Üyetürk, Uğur Üyetürk, and Yusufhan Yazır. 2022. “The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis”. Experimed 12 (3): 238-42. https://doi.org/10.26650/experimed.1195246.
EndNote
Erimşah S, Çetinkaya A, Üyetürk Ü, Üyetürk U, Yazır Y (December 1, 2022) The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis. Experimed 12 3 238–242.
IEEE
[1]S. Erimşah, A. Çetinkaya, Ü. Üyetürk, U. Üyetürk, and Y. Yazır, “The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis”, Experimed, vol. 12, no. 3, pp. 238–242, Dec. 2022, doi: 10.26650/experimed.1195246.
ISNAD
Erimşah, Sevilay - Çetinkaya, Ayhan - Üyetürk, Ümmügül - Üyetürk, Uğur - Yazır, Yusufhan. “The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis”. Experimed 12/3 (December 1, 2022): 238-242. https://doi.org/10.26650/experimed.1195246.
JAMA
1.Erimşah S, Çetinkaya A, Üyetürk Ü, Üyetürk U, Yazır Y. The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis. Experimed. 2022;12:238–242.
MLA
Erimşah, Sevilay, et al. “The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis”. Experimed, vol. 12, no. 3, Dec. 2022, pp. 238-42, doi:10.26650/experimed.1195246.
Vancouver
1.Sevilay Erimşah, Ayhan Çetinkaya, Ümmügül Üyetürk, Uğur Üyetürk, Yusufhan Yazır. The Antioxidant Effects of Sesamol on Bleomycin-Induced Oral Submucous Fibrosis. Experimed. 2022 Dec. 1;12(3):238-42. doi:10.26650/experimed.1195246